Use of edaravone in combination with endovascular reperfusion therapy appears to be effective in the treatment of patients with acute ischaemic stroke, resulting in better functional outcomes and lower adverse events, a study has found.
New drug applications approved by US FDA as of 01 - 15 March 2019 which includes New Molecular Entities (NMEs) and new biologics. It
does not include Tentative Approvals. Supplemental approvals may have
occurred since the original approval date.